MetaADEDB 2.0 @ LMMD
Pramipexole
(APVQOOKHDZVJEX-QTPLPEIMSA-N)
Structure
SMILES
CCCN[C@H]1CCc2c(C1)sc(n2)N.O.Cl.Cl
Molecular Formula:
C10H21Cl2N3OS
Molecular Weight:
302.264
Log P:
4.0940
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
5
TPSA:
88.41
CAS Number(s):
191217-81-9; 191712-81-9
Synonym(s)
1.
Pramipexole
2.
2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
3.
2-Amino-6-propylaminotetrahydrobenzothiazole
4.
4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine
5.
6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
6.
Dexpramipexole
7.
KNS 760704
8.
KNS-760704
9.
KNS760704
10.
Mirapex
11.
Pramipexol
12.
Pramipexol Dihydrobromide, (+-)-isomer
13.
Pramipexol Dihydrochloride, (S)-isomer
14.
Pramipexol, (+-)-isomer
15.
Pramipexol, (R)-isomer
16.
Pramipexole Dihydrochloride
17.
Pramipexole Dihydrochloride Anhydrous
18.
Pramipexole Hydrochloride Monohydrate
19.
SND 919CL2x
20.
SND-919
21.
SND-919CL2x
22.
SND919CL2x
23.
Sifrol
24.
2 Amino 6 propylaminotetrahydrobenzothiazole
25.
SND 919
External Link(s)
MeSHD000077487
PubChem Compound166589
91827764
ChEBI51147
CHEMBLCHEMBL3182733
KEGGdr:D00559
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Obsessive-Compulsive DisorderFAERS: 843
Canada Vigilance: 18
Canada Vigilance
US FAERS
2Emotional distressFAERS: 743
Canada Vigilance: 1
Canada Vigilance
US FAERS
3PainFAERS: 544
Canada Vigilance: 4
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 294
Canada Vigilance: 21
Canada Vigilance
US FAERS
5Compulsive shoppingFAERS: 293
Canada Vigilance: 12
Canada Vigilance
US FAERS
6AnxietyFAERS: 265
Canada Vigilance: 4
Canada Vigilance
US FAERS
7SomnolenceFAERS: 187
Canada Vigilance: 6
Canada Vigilance
US FAERS
8HyperphagiaFAERS: 151
Canada Vigilance: 6
Canada Vigilance
US FAERS
9GamblingFAERS: 149
Canada Vigilance: 4
Canada Vigilance
US FAERS
10StressFAERS: 140
Canada Vigilance: 2
Canada Vigilance
US FAERS
11NauseaFAERS: 133US FAERS
12FatigueFAERS: 94US FAERS
13Restless Legs SyndromeFAERS: 83
Canada Vigilance: 3
Canada Vigilance
US FAERS
14DizzinessFAERS: 69
Canada Vigilance: 2
Canada Vigilance
US FAERS
15Economic problemFAERS: 60US FAERS
16HeadacheFAERS: 60US FAERS
17Sudden onset of sleepFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Disease ProgressionFAERS: 50US FAERS
19TremorFAERS: 50
Canada Vigilance: 7
Canada Vigilance
US FAERS
20Suicide attemptFAERS: 48
Canada Vigilance: 10
Canada Vigilance
US FAERS
21Feeling abnormalFAERS: 46US FAERS
22Personality ChangeFAERS: 45
Canada Vigilance: 4
Canada Vigilance
US FAERS
23VomitingFAERS: 44
Canada Vigilance: 3
Canada Vigilance
US FAERS
24Limb discomfortFAERS: 43US FAERS
25Compulsive sexual behaviourFAERS: 41
Canada Vigilance: 3
Canada Vigilance
US FAERS
26Activities of daily living impairedFAERS: 36US FAERS
27AstheniaFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
28Unevaluable eventFAERS: 34US FAERS
29RestlessnessFAERS: 31US FAERS
30Joint swellingFAERS: 25US FAERS
31AmnesiaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
32Chest PainFAERS: 24US FAERS
33MalaiseFAERS: 24US FAERS
34HypotensionFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
35SyncopeFAERS: 22US FAERS
36Memory impairmentFAERS: 21US FAERS
37MyalgiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Bipolar DisorderFAERS: 20US FAERS
39Inappropriate schedule of drug administrationFAERS: 20US FAERS
40ArthralgiaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Drug DependenceFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
42OverdoseFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
43AngerFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Abdominal discomfortFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
45DependenceFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
46Myocardial InfarctionFAERS: 16US FAERS
47SomnambulismFAERS: 16US FAERS
48Emotional disorderFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
49PalpitationsFAERS: 15US FAERS
50Weight decreasedFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
51DyspepsiaFAERS: 14US FAERS
52Mood disorder due to a general medical conditionFAERS: 14US FAERS
53ParanoiaFAERS: 14
Canada Vigilance: 6
Canada Vigilance
US FAERS
54HypomaniaFAERS: 13US FAERS
55Bipolar I disorderFAERS: 12US FAERS
56Quality of life decreasedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
57PneumoniaFAERS: 11US FAERS
58Visual ImpairmentFAERS: 11US FAERS
59Abdominal PainFAERS: 10US FAERS
60Alcohol abuseFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
61AlopeciaFAERS: 10US FAERS
62Back PainFAERS: 10US FAERS
63Completed SuicideFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
64DysarthriaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Incorrect dose administeredFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Mood swingsFAERS: 10US FAERS
67Neuroleptic Malignant SyndromeFAERS: 10US FAERS
68PruritusFAERS: 10US FAERS
69BankruptcyFAERS: 9US FAERS
70Burning sensationFAERS: 9US FAERS
71Compulsive hoardingFAERS: 9US FAERS
72CryingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Diabetes MellitusFAERS: 9US FAERS
74Disturbance in sexual arousalFAERS: 9US FAERS
75Drug withdrawal syndromeFAERS: 9US FAERS
76Feeling jitteryFAERS: 9US FAERS
77HypersensitivityFAERS: 9US FAERS
78Medication ErrorFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
79NervousnessFAERS: 9US FAERS
80Cerebrovascular accidentFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Chest discomfortFAERS: 8US FAERS
82DysgeusiaFAERS: 8US FAERS
83HypersomniaFAERS: 8US FAERS
84Initial insomniaFAERS: 8US FAERS
85Musculoskeletal stiffnessFAERS: 8US FAERS
86Respiratory FailureFAERS: 8US FAERS
87AphasiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
88ChromaturiaFAERS: 7US FAERS
89ConstipationFAERS: 7US FAERS
90DisabilityFAERS: 7US FAERS
91DisorientationFAERS: 7US FAERS
92Erection increasedFAERS: 7US FAERS
93Impaired work abilityFAERS: 7US FAERS
94Middle insomniaFAERS: 7US FAERS
95Partner stressFAERS: 7US FAERS
96TinnitusFAERS: 7US FAERS
97Toxicity to various agentsFAERS: 7US FAERS
98AgitationFAERS: 6US FAERS
99Blood creatine phosphokinase increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Cerebral InfarctionFAERS: 6US FAERS
101CholelithiasisFAERS: 6US FAERS
102DehydrationFAERS: 6US FAERS
103Depressed Level of ConsciousnessFAERS: 6US FAERS
104DystoniaFAERS: 6US FAERS
105Mental impairmentFAERS: 6US FAERS
106Muscle RigidityFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Muscle tightnessFAERS: 6US FAERS
108NarcolepsyFAERS: 6US FAERS
109Peripheral swellingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Product substitution issueFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
111TheftFAERS: 6US FAERS
112Tooth InfectionFAERS: 6US FAERS
113AbasiaFAERS: 5US FAERS
114Accidental overdoseFAERS: 5US FAERS
115AnorexiaFAERS: 5US FAERS
116DrowningFAERS: 5US FAERS
117Drug dispensing errorFAERS: 5US FAERS
118EcchymosisFAERS: 5US FAERS
119EpistaxisFAERS: 5US FAERS
120Erectile dysfunctionFAERS: 5US FAERS
121Night sweatsFAERS: 5US FAERS
122Poor quality sleepFAERS: 5US FAERS
123Sexual DysfunctionFAERS: 5US FAERS
124Skin lacerationFAERS: 5US FAERS
125Urinary RetentionFAERS: 5US FAERS
126Acute myocardial infarctionFAERS: 4US FAERS
127Adverse eventFAERS: 4US FAERS
128AkinesiaFAERS: 4US FAERS
129ArthritisFAERS: 4US FAERS
130AsthmaFAERS: 4US FAERS
131Atrial FibrillationFAERS: 4US FAERS
132Cold sweatFAERS: 4US FAERS
133DeliriumFAERS: 4US FAERS
134DementiaFAERS: 4US FAERS
135Depressed moodFAERS: 4US FAERS
136DiplopiaFAERS: 4US FAERS
137Drug screen false positiveFAERS: 4US FAERS
138DysphoniaFAERS: 4US FAERS
139ErythemaFAERS: 4US FAERS
140Excessive sexual fantasiesFAERS: 4US FAERS
141Flank PainFAERS: 4US FAERS
142FlushingFAERS: 4US FAERS
143Impaired driving abilityFAERS: 4US FAERS
144Intestinal ObstructionFAERS: 4US FAERS
145Joint injuryFAERS: 4US FAERS
146Joint stiffnessFAERS: 4US FAERS
147LethargyFAERS: 4US FAERS
148Obsessive thoughtsFAERS: 4US FAERS
149Pharmaceutical product complaintFAERS: 4US FAERS
150PolydipsiaFAERS: 4US FAERS
151Psychiatric symptomFAERS: 4US FAERS
152RhabdomyolysisFAERS: 4US FAERS
153SepsisFAERS: 4US FAERS
154Skin UlcerFAERS: 4US FAERS
155Spontaneous penile erectionFAERS: 4US FAERS
156Throat irritationFAERS: 4US FAERS
157Urinary IncontinenceFAERS: 4US FAERS
158Visual disturbanceFAERS: 4US FAERS
159Accidental drug intake by childFAERS: 3US FAERS
160Accidental exposureFAERS: 3US FAERS
161AnhedoniaFAERS: 3US FAERS
162Ankle FractureFAERS: 3US FAERS
163Blood cholesterol increasedFAERS: 3US FAERS
164Blood creatinine increasedFAERS: 3US FAERS
165Blood glucose increasedFAERS: 3US FAERS
166Borderline Personality DisorderFAERS: 3US FAERS
167Brain scan abnormalFAERS: 3US FAERS
168BruxismFAERS: 3US FAERS
169ChillsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Drug administration errorFAERS: 3US FAERS
171Euphoric moodFAERS: 3US FAERS
172Feeling ColdFAERS: 3US FAERS
173FractureFAERS: 3US FAERS
174Gastric BypassFAERS: 3US FAERS
175GlaucomaFAERS: 3US FAERS
176Grip strength decreasedFAERS: 3US FAERS
177IleusFAERS: 3US FAERS
178Inappropriate schedule of product administrationFAERS: 3US FAERS
179Incorrect route of drug administrationFAERS: 3US FAERS
180Irritable Bowel SyndromeFAERS: 3US FAERS
181Mental status changesFAERS: 3US FAERS
182Muscle FatigueFAERS: 3US FAERS
183Musculoskeletal PainFAERS: 3US FAERS
184MydriasisFAERS: 3US FAERS
185Nerve injuryFAERS: 3US FAERS
186Post-Traumatic Stress DisorderFAERS: 3US FAERS
187Product use in unapproved indicationFAERS: 3US FAERS
188Retroperitoneal fibrosisFAERS: 3US FAERS
189Sexual abuseFAERS: 3US FAERS
190SwellingFAERS: 3US FAERS
191Therapeutic response unexpectedFAERS: 3US FAERS
192Wrong technique in product usage processFAERS: 3US FAERS
193Abnormal weight gainFAERS: 2US FAERS
194Acute psychosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Angina PectorisFAERS: 2US FAERS
196AphagiaFAERS: 2US FAERS
197AphoniaFAERS: 2US FAERS
198ArteriosclerosisFAERS: 2US FAERS
199BlepharospasmFAERS: 2US FAERS
200BlindnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Blood pressure fluctuationFAERS: 2US FAERS
202CataplexyFAERS: 2US FAERS
203CellulitisFAERS: 2US FAERS
204Clostridium difficile infectionFAERS: 2US FAERS
205DeafnessFAERS: 2US FAERS
206Deep Brain StimulationFAERS: 2US FAERS
207Deep Vein ThrombosisFAERS: 2US FAERS
208DeformityFAERS: 2US FAERS
209Depression suicidalFAERS: 2US FAERS
210DiscomfortFAERS: 2US FAERS
211Dopamine dysregulation syndromeFAERS: 2US FAERS
212Drug ToleranceFAERS: 2US FAERS
213Drug abuseFAERS: 2US FAERS
214Drug effect delayedFAERS: 2US FAERS
215Drug effect incompleteFAERS: 2US FAERS
216Drug level increasedFAERS: 2US FAERS
217DysgraphiaFAERS: 2US FAERS
218DysuriaFAERS: 2US FAERS
219EnteroceleFAERS: 2US FAERS
220EosinophiliaFAERS: 2US FAERS
221EructationFAERS: 2US FAERS
222ExhibitionismFAERS: 2US FAERS
223Feeling of body temperature changeFAERS: 2US FAERS
224FibromyalgiaFAERS: 2US FAERS
225Food AllergyFAERS: 2US FAERS
226Food cravingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
227GastrocoeleFAERS: 2US FAERS
228General physical condition abnormalFAERS: 2US FAERS
229Hallucinations, mixedFAERS: 2US FAERS
230HostilityFAERS: 2US FAERS
231HypokinesiaFAERS: 2US FAERS
232Libido disorderFAERS: 2US FAERS
233Loss of dreamingFAERS: 2US FAERS
234Lower respiratory tract infectionFAERS: 2US FAERS
235Musculoskeletal discomfortFAERS: 2US FAERS
236NasopharyngitisFAERS: 2US FAERS
237Neck PainFAERS: 2US FAERS
238NeuropathyFAERS: 2US FAERS
239OverweightFAERS: 2US FAERS
240Paranasal sinus hypersecretionFAERS: 2US FAERS
241Pelvic Floor Muscle WeaknessFAERS: 2US FAERS
242PneumothoraxFAERS: 2US FAERS
243Product counterfeitFAERS: 2US FAERS
244Rebound effectFAERS: 2US FAERS
245RetchingFAERS: 2US FAERS
246Rotator cuff syndromeFAERS: 2US FAERS
247ScreamingFAERS: 2US FAERS
248Sexual activity increasedFAERS: 2US FAERS
249ShockFAERS: 2US FAERS
250ShopliftingFAERS: 2US FAERS
251Skin irritationFAERS: 2US FAERS
252Skin lesionFAERS: 2US FAERS
253Sleep TalkingFAERS: 2US FAERS
254Spinal column stenosisFAERS: 2US FAERS
255TensionFAERS: 2US FAERS
256Therapy cessationFAERS: 2US FAERS
257ThirstFAERS: 2US FAERS
258Urinary tract infectionFAERS: 2US FAERS
259VertigoFAERS: 2US FAERS
260Vitreous floatersFAERS: 2US FAERS
261Abnormal sleep-related eventFAERS: 1US FAERS
262Acute kidney injuryFAERS: 1US FAERS
263AgeusiaFAERS: 1US FAERS
264AkathisiaFAERS: 1US FAERS
265Alcohol withdrawal syndromeFAERS: 1US FAERS
266AnalgesiaFAERS: 1US FAERS
267AnorgasmiaFAERS: 1US FAERS
268ApathyFAERS: 1US FAERS
269Apparent life threatening eventFAERS: 1US FAERS
270AppendicitisFAERS: 1US FAERS
271Basal cell carcinomaFAERS: 1US FAERS
272Blood alcohol increasedFAERS: 1US FAERS
273Blood alkaline phosphatase increasedFAERS: 1US FAERS
274Blood follicle stimulating hormone decreasedFAERS: 1US FAERS
275Blood glucose decreasedFAERS: 1US FAERS
276Blood glucose fluctuationFAERS: 1US FAERS
277Blood potassium decreasedFAERS: 1US FAERS
278Blood prolactin decreasedFAERS: 1US FAERS
279Blood sodium decreasedFAERS: 1US FAERS
280Blood testosterone decreasedFAERS: 1US FAERS
281Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
282Blood triglycerides increasedFAERS: 1US FAERS
283Bone painFAERS: 1US FAERS
284BradycardiaFAERS: 1US FAERS
285Breast cosmetic surgeryFAERS: 1US FAERS
286Breast tendernessFAERS: 1US FAERS
287Breath alcohol test positiveFAERS: 1US FAERS
288BronchitisFAERS: 1US FAERS
289Cardiac ArrestFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
290Cardiac discomfortFAERS: 1US FAERS
291CataractFAERS: 1US FAERS
292Cerebral PalsyFAERS: 1US FAERS
293Change in sustained attentionFAERS: 1US FAERS
294Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
295ClonusFAERS: 1US FAERS
296Compression fractureFAERS: 1US FAERS
297Congenital cystic kidney diseaseFAERS: 1US FAERS
298Contraindicated product administeredFAERS: 1US FAERS
299Conversion disorderFAERS: 1US FAERS
300Coronary Artery DiseaseFAERS: 1US FAERS
301Culture positiveFAERS: 1US FAERS
302Decreased eye contactFAERS: 1US FAERS
303Disease recurrenceFAERS: 1US FAERS
304DissociationFAERS: 1US FAERS
305DroolingFAERS: 1US FAERS
306Dropped head syndromeFAERS: 1US FAERS
307Drug abuserFAERS: 1US FAERS
308Drug ineffective for unapproved indicationFAERS: 1US FAERS
309Drug level below therapeuticFAERS: 1US FAERS
310Drug prescribing errorFAERS: 1US FAERS
311Drug screen positiveFAERS: 1US FAERS
312Dry skinFAERS: 1US FAERS
313Emotional povertyFAERS: 1US FAERS
314Epigastric discomfortFAERS: 1US FAERS
315Erythema NodosumFAERS: 1US FAERS
316Expired drug administeredFAERS: 1US FAERS
317Feelings of worthlessnessFAERS: 1US FAERS
318FlatulenceFAERS: 1US FAERS
319Fluid overloadFAERS: 1US FAERS
320Foreign body traumaFAERS: 1US FAERS
321FrostbiteFAERS: 1US FAERS
322Gastrointestinal motility disorderFAERS: 1US FAERS
323GastrostomyFAERS: 1US FAERS
324General symptomFAERS: 1US FAERS
325Genitourinary operationFAERS: 1US FAERS
326Global AmnesiaFAERS: 1US FAERS
327Hepatic cancer metastaticFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
328HerniaFAERS: 1US FAERS
329Hip surgeryFAERS: 1US FAERS
330HungerFAERS: 1US FAERS
331HypophagiaFAERS: 1US FAERS
332HypothyroidismFAERS: 1US FAERS
333HypoventilationFAERS: 1US FAERS
334HypoxiaFAERS: 1US FAERS
335Impaired gastric emptyingFAERS: 1US FAERS
336Impaired self-careFAERS: 1US FAERS
337IncontinenceFAERS: 1US FAERS
338Incorrect drug administration rateFAERS: 1US FAERS
339Incorrect route of product administrationFAERS: 1US FAERS
340Increased upper airway secretionFAERS: 1US FAERS
341Injury asphyxiationFAERS: 1US FAERS
342Intentional drug misuseFAERS: 1US FAERS
343Intentional product use issueFAERS: 1US FAERS
344Intervertebral Disc DegenerationFAERS: 1US FAERS
345LacerationFAERS: 1US FAERS
346LaryngospasmFAERS: 1US FAERS
347LeukopeniaFAERS: 1US FAERS
348Lichen PlanusFAERS: 1US FAERS
349Lip swellingFAERS: 1US FAERS
350LymphadenopathyFAERS: 1US FAERS
351Macular degenerationFAERS: 1US FAERS
352Malignant melanoma in situFAERS: 1US FAERS
353MastocytosisFAERS: 1US FAERS
354Medication residueFAERS: 1US FAERS
355Medication residue presentFAERS: 1US FAERS
356Migraine with AuraFAERS: 1US FAERS
357Miscarriage of partnerFAERS: 1US FAERS
358Musculoskeletal chest painFAERS: 1US FAERS
359MyoclonusFAERS: 1US FAERS
360MyosclerosisFAERS: 1US FAERS
361NephrolithiasisFAERS: 1US FAERS
362Nephrotic SyndromeFAERS: 1US FAERS
363NeuralgiaFAERS: 1US FAERS
364Nicotine DependenceFAERS: 1US FAERS
365No adverse eventFAERS: 1US FAERS
366NocturiaFAERS: 1US FAERS
367Nuchal RigidityFAERS: 1US FAERS
368Optic AtrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
369OsteitisFAERS: 1US FAERS
370OsteomalaciaFAERS: 1US FAERS
371OsteoporosisFAERS: 1US FAERS
372PallorFAERS: 1US FAERS
373PancreatectomyFAERS: 1US FAERS
374Panic DisorderFAERS: 1US FAERS
375Paradoxical drug reactionFAERS: 1US FAERS
376Parent-child problemFAERS: 1US FAERS
377PericarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
378Phobia of drivingFAERS: 1US FAERS
379Physical abuseFAERS: 1US FAERS
380PoisoningFAERS: 1US FAERS
381Poor personal hygieneFAERS: 1US FAERS
382Post procedural infectionFAERS: 1US FAERS
383Precancerous skin lesionFAERS: 1US FAERS
384Prescribed overdoseFAERS: 1US FAERS
385PresyncopeFAERS: 1US FAERS
386Procedural complicationFAERS: 1US FAERS
387Product dispensing errorFAERS: 1US FAERS
388Product measured potency issueFAERS: 1US FAERS
389Product preparation errorFAERS: 1US FAERS
390Product quality issueFAERS: 1US FAERS
391Pulmonary EmbolismFAERS: 1US FAERS
392Pulmonary FibrosisFAERS: 1US FAERS
393Reaction to preservativesFAERS: 1US FAERS
394Rectal ProlapseFAERS: 1US FAERS
395Rehabilitation therapyFAERS: 1US FAERS
396Respiratory distressFAERS: 1US FAERS
397Rheumatoid ArthritisFAERS: 1US FAERS
398Sense of oppressionFAERS: 1US FAERS
399Sensorimotor disorderFAERS: 1US FAERS
400SinusitisFAERS: 1US FAERS
401Skin WrinklingFAERS: 1US FAERS
402Skin test positiveFAERS: 1US FAERS
403Sleep-related eating disorderFAERS: 1US FAERS
404SluggishnessFAERS: 1US FAERS
405Spermatozoa progressive motility abnormalFAERS: 1US FAERS
406Squamous cell carcinomaFAERS: 1US FAERS
407StaringFAERS: 1US FAERS
408StomatitisFAERS: 1US FAERS
409TachyphreniaFAERS: 1US FAERS
410Tardive DyskinesiaFAERS: 1US FAERS
411Temperature regulation disorderFAERS: 1US FAERS
412Therapeutic product ineffectiveFAERS: 1US FAERS
413Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
414Therapeutic reaction time decreasedFAERS: 1US FAERS
415Therapeutic response changedFAERS: 1US FAERS
416Therapeutic response delayedFAERS: 1US FAERS
417Tobacco userFAERS: 1US FAERS
418Tooth LossFAERS: 1US FAERS
419TorticollisFAERS: 1US FAERS
420TransvestismFAERS: 1US FAERS
421TrismusFAERS: 1US FAERS
422TuberculosisFAERS: 1US FAERS
423UnemploymentFAERS: 1US FAERS
424Unresponsive to verbal stimuliFAERS: 1US FAERS
425UrticariaFAERS: 1US FAERS
426Victim of sexual abuseFAERS: 1US FAERS
427VoyeurismFAERS: 1US FAERS
428Walking aid userFAERS: 1US FAERS
429WheezingFAERS: 1US FAERS
430White blood cell count decreasedFAERS: 1US FAERS
431Wrong drug administeredFAERS: 1US FAERS
432Wrong technique in drug usage processFAERS: 1US FAERS
433nervous system disorderFAERS: 1US FAERS
434Alanine Aminotransferase IncreasedCanada Vigilance: 1Canada Vigilance
435Aspartate Aminotransferase IncreasedCanada Vigilance: 1Canada Vigilance
436BradykinesiaCanada Vigilance: 1Canada Vigilance
437DysphemiaCanada Vigilance: 1Canada Vigilance
438EpilepsyCanada Vigilance: 1Canada Vigilance
439Pathological fractureCanada Vigilance: 1Canada Vigilance
440Psychological TraumaCanada Vigilance: 1Canada Vigilance
441Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.